In clonal hematopoiesis of indeterminate potential (CHIP), mutations in are detected in blood cells that have been linked to increased risk of cancer and other diseases.

As one of the very few CHIP clinics in the U.S., we are working with patients with CHIP mutations to determine which mutations are the most problematic and carries the highest risk for blood cancer development in their life time.

If you are interested in learning more about Dr. Zhang’s CHIP clinic, please take a look at the clinic overview by Stanford Medicine. If you are a person with CHIP, please feel free to send us a note via the CONTACTS page.